MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma
Shuying Chen(Brigham and Women's Hospital), Hui‐Chuan Sun(Fudan University)
Cited by 33
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
|The Lancet Oncology|2023|243
Oral drug delivery platforms for biomedical applications
|Materials Today|2023|123
NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma
|Cell Death and Disease|2020|59